Morphine-Tolerant Mice Retained Responses to Systemic and Topical WIN 55,212-2

In a mouse heat-response experiment, morphine tolerance did not reduce the antinociceptive potency of WIN 55,212-2 given systemically or topically. This was a route-specific cross-tolerance study, not evidence that topical cannabis products treat opioid-tolerant patients.

The researchers compared exposure routes

Mice became morphine-tolerant through implanted morphine pellets or repeated topical morphine administration. They were then challenged with WIN 55,212-2, a synthetic agonist acting at CB1 and CB2 receptors. The cannabinoid challenge was delivered under the skin or topically.

The endpoint was a tail-flick response

Antinociception was inferred from longer tail-flick latencies to noxious radiant heat. Morphine pellets did not attenuate WIN potency through either tested route. Repeated topical morphine also did not attenuate the potency of topical WIN. The null cross-tolerance findings therefore applied to defined combinations of exposure route and heat-response measurement.

Why this does not resolve all opioid–cannabinoid questions

The authors interpreted the observations as supporting independence of the relevant antinociceptive mechanisms. That interpretation remains bounded by the experiment. It does not establish an absence of cross-tolerance for every cannabinoid, pain condition, species or dosing history. Nor was a commercial topical cannabis formulation tested.

For an evidence review, the important contribution is the direct route comparison within one model. A retained response to a synthetic cannabinoid in morphine-tolerant mice is narrower than demonstrated clinical pain relief, and it provides no individual measure of intoxication or functional safety.

Related: interpreting cannabis tolerance claims.

Research cited

Yeşilyurt O; Dogrul A. Lack of cross-tolerance to the antinociceptive effects of systemic and topical cannabinoids in morphine-tolerant mice. Neuroscience letters (2004). doi:10.1016/j.neulet.2004.08.052. Findings discussed from the study abstract.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

THC and CB1 Blockade Changed Fat Intake Differently Across Feeding Schedules in Female Rats

A female-rat feeding study found that THC increased fat intake in one access schedule while rimonabant reduced intake in another. The feeding history and experimental group mattered to the direction and persistence of the response. Limited access created different eating patterns Rats had unrestricted chow and water, with groups differing…

Spread the love

Read Article: THC and CB1 Blockade Changed Fat Intake Differently Across Feeding Schedules in Female Rats

mTOR Inhibition Prevented Some THC Memory Effects When Given Before Exposure, Not After Cessation

In a mouse THC study, mTOR inhibition prevented selected memory-related effects when given before exposure but did not prevent a residual cognitive deficit when introduced after chronic THC stopped. Timing changed the intervention's result. Acute effects separated by endpoint Temsirolimus prevented acute anxiety-like and amnesic-like effects. THC-related anxiolysis, hypothermia, reduced…

Spread the love

Read Article: mTOR Inhibition Prevented Some THC Memory Effects When Given Before Exposure, Not After Cessation

Partial MAGL Inhibition Preserved Repeated Pain-Response and Gastric Benefits in Mice

A mouse study found that repeated lower-dose JZL184 preserved antinociceptive and gastroprotective effects that became tolerant under higher-dose regimens. The result supports a dose-dependent experimental window, not a validated human treatment schedule. Two disease-related models were used Researchers examined neuropathic pain after sciatic nerve constriction and gastric hemorrhage induced by…

Spread the love

Read Article: Partial MAGL Inhibition Preserved Repeated Pain-Response and Gastric Benefits in Mice

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us